FDA Investigator: Edward H. Maticka

- Edward H. Maticka first started conducting FDA inspections in 2000, with the last inspection in 2006. Over that time, Edward H. Maticka has conducted 132 inspections at 93 companies across 93 sites.

Get Edward Maticka's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 L Enterprises LLC, Knoxville | 2006

Out-of-stock
Edward H. Maticka
Medical Devices & Rad Health Form 483

FDA 483 Chattem Chemicals, Inc., Chattanooga | 2006

Out-of-stock
Edward H. Maticka
Human Drug Form 483

FDA 483 King Legacy, a wholly owned subsidiary of Pfizer, Bristol | 2006

Out-of-stock
Edward H. Maticka
Human Drug Form 483

FDA 483 Eastman Chemical Company/Tennessee Operations, Kingsport | 2006

Out-of-stock
Edward H. Maticka
Human Drug Form 483

FDA 483 Two Rivers LLC, Tazewell | 2006

Out-of-stock
Edward H. Maticka
Medical Devices & Rad Health Form 483

FDA 483 Marden, David W, DO, Bristol | 2006

Out-of-stock
Edward H. Maticka
Human Drug Form 483

FDA 483 Foster III Malcolm T MD, Knoxville | 2006

Out-of-stock
Edward H. Maticka
Medical Devices & Rad Health Form 483

FDA 483 Darryl Millis DVM, Knoxville | 2006

Out-of-stock
Edward H. Maticka
Animal Drugs & Feed Form 483

FDA 483 Mildred Bass, DVM, Knoxville | 2005

Out-of-stock
Edward H. Maticka
Animal Drugs & Feed Form 483

FDA 483 Tennessee Farmers Cooperative, Rockford | 2005

Out-of-stock
Edward H. Maticka
Animal Drugs & Feed Form 483

FDA 483 Tennessee Farmers Cooperative, Rockford | 2005

Out-of-stock
Edward H. Maticka
Animal Drugs & Feed Form 483

FDA 483 Craig R Reinemeyer, DVM PhD, Rockwood | 2005

Out-of-stock
Edward H. Maticka
Animal Drugs & Feed Form 483

FDA 483 Crown Laboratories Inc/dba Del-Ray Dermatologicals, Johnson City | 2005

Out-of-stock
Edward H. Maticka
Human Drug Form 483

FDA 483 Morin, David J., MD, Bristol | 2005

Out-of-stock
Edward H. Maticka
Human Drug Form 483